7.54
price up icon7.56%   0.53
after-market After Hours: 7.60 0.06 +0.80%
loading

Eikon Therapeutics Inc Stock (EIKN) Forecast

The Eikon Therapeutics Inc (EIKN) stock price forecast for the next 30 days is generally negative, with an average analyst price target of $6.4924, representing a -13.89% decrease from the current price of $7.54. The highest analyst price target is $9.1942, and the lowest is $3.7906.

Disclaimer: The information on this page is not intended to be financial advice. It is for general information only and should not be used to make any investment decisions. Please consult with a professional financial advisor before making any investment decisions.
12-Month EIKN Price Target
Average 4.9931 (-33.78% Downside)
loading

Is Eikon Therapeutics Inc (EIKN) A Buy Now?

Oscillators
Name Value Action
RSI(14) 41.86 Neutral
STOCH(9,6) 37.15 Neutral
STOCHRSI(14) 100.00 Sell
MACD(12,26) -0.6364 Buy
ADX(14) 23.30 Neutral
William %R -36.28 Neutral
CCI(14) -5.9479 Neutral
Buy: 1 Sell: 1 Neutral: 5
Summary: Neutral
Moving Averages
Period Simple Exponential
MA10
7.342
Buy
7.4074
Buy
MA20
7.7895
Sell
7.8631
Sell
MA50
9.412
Sell
8.8504
Sell
MA100
9.7183
Sell
9.7045
Sell
MA200
9.3294
Sell
0.00
Buy
Buy: 3 Sell: 7 Neutral: 0
Summary: Sell
According to our latest analysis, EIKN could be considered a Moderate Sell, with 17 technical analysis indicators signaling 4 Buy signals, 8 signaling Sell signals and 5 Neutral signals. This might not be a good time to consider opening new positions on EIKN, as trading bearish markets can be challenging and may result in losses.
  1. RSI (Relative Strength Index): The RSI(14) value of 41.86 indicates that EIKN is neither overbought nor oversold. It suggests a neutral sentiment in the short term.
  2. STOCH (Stochastic Oscillator): The STOCH value of 37.15 indicates that EIKN is neither overbought nor oversold. It indicates a balanced market sentiment without any extreme buying or selling pressure.
  3. STOCHRSI (Stochastic Relative Strength Index): The STOCHRSI value of 100 indicates that EIKN is oversold. This suggests that EIKN price is at or near the highest level relative to its recent price history.
  4. ADX (Average Directional Index): The ADX value of The ADX value of 23.3 suggests that there may be some movement in price, but it lacks strength or conviction.
  5. CCI (Commodity Channel Index): A CCI(14) value of A CCI(14) value of -5.9479 indicates that EIKN is not in oversold or overbought territory. It suggests a neutral sentiment in the short term.

Long-term EIKN price forecast for 2025, 2030, 2035, 2040, 2045 and 2050

Based on our analysis about Eikon Therapeutics Inc financial reports and earnings history, Eikon Therapeutics Inc (EIKN) stock could reach $20.83 by 2030, $87.77 by 2040 and $112.24 by 2050. See the projected annual prices until 2050 of the Eikon Therapeutics Inc stock below:

  • Eikon Therapeutics Inc (EIKN) is expected to reach an average price of $60.58 in 2035, with a high prediction of $63.14 and a low estimate of $60.62. This indicates an $703.39% rise from the last recorded price of $7.54.
  • Eikon Therapeutics Inc (EIKN) stock is projected to chart a bullish course in 2040, with an average price target of $84.83, representing an $1,025% surge from its current level. The forecast ranges from a conservative $85.57 to a sky-high $87.77.
  • Our analysts predict Eikon Therapeutics Inc (EIKN) to jump 1,195% by 2045, soaring from $99.46 to an average price of $97.66, potentially reaching $106.61. While $99.46 is the low estimate, the potential upside is significant.
  • Eikon Therapeutics Inc (EIKN) stock is expected to climb by 2050, reaching an average of $105.69, a $1,302% jump from its current level. However, a wide range of estimates exists, with high and low targets of $112.24 and $105.95, respectively, highlighting the market's uncertainty.

Eikon Therapeutics Inc Stock (EIKN) Year by Year Forecast

Eikon Therapeutics Inc Stock (EIKN) Price Forecast for 2026

The predicted value for Eikon Therapeutics Inc (EIKN) in 2026 is set at an average of $9.7056. Estimates vary from a peak of $17.40 to a trough of $2.0112, indicating an +28.72% surge from the present price of $7.54.
Month Average Low High Change from today's price
November, 2026 $4.8827 $3.7906 $9.1942 -35.24%
December, 2026 $2.4312 $2.0112 $5.3948 -67.76%

Eikon Therapeutics Inc Stock (EIKN) Price Forecast for 2027

For 2027, Stockscan's Analyst expects the average price target for Eikon Therapeutics Inc (EIKN) is $4.9931, with a high forecast of $9.8747 and a low forecast of $0.1115. This indicates an -33.78% decrease from the last price of $7.54.
Month Average Low High Change from today's price
January, 2027 $3.4797 $1.6075 $5.7654 -53.85%
February, 2027 $5.0081 $2.8418 $7.4985 -33.58%
March, 2027 $7.6787 $2.3624 $8.1687 +1.84%
April, 2027 $3.8972 $3.7172 $8.1508 -48.31%
May, 2027 $6.4378 $3.9893 $9.8747 -14.62%
June, 2027 $4.7763 $4.2163 $7.312 -36.65%
July, 2027 $3.6647 $3.1726 $5.2484 -51.40%
August, 2027 $0.6473 $0.1115 $3.8869 -91.42%
September, 2027 $3.8803 $0.6331 $1.9319 -48.54%
October, 2027 $1.0534 $3.7219 $3.0676 -86.03%
November, 2027 $1.2178 $2.1422 $2.8649 -83.85%
December, 2027 $2.5453 $1.448 $1.7553 -66.24%

Eikon Therapeutics Inc Stock (EIKN) Price Forecast for 2028

In 2028, Eikon Therapeutics Inc (EIKN) is projected to reach an average price of $4.8395, with a high projection of $9.6364 and a low estimate of $0.0425. This indicates an -35.82% fall from the last price of $7.54.
Month Average Low High Change from today's price
January, 2028 $0.2059 $0.1941 $2.8717 -97.27%
February, 2028 $0.3471 $0.5571 $0.3802 -95.40%
March, 2028 $1.5598 $0.2029 $5.2403 -79.31%
April, 2028 $0.2432 $0.0425 $2.9541 -96.77%
May, 2028 $7.97 $0.434 $5.07 +5.70%
June, 2028 $6.9846 $7.4173 $6.2109 -7.37%
July, 2028 $10.08 $9.8919 $9.1192 +33.72%
August, 2028 $9.2624 $9.5437 $9.6364 +22.84%
September, 2028 $6.862 $7.372 $8.801 -8.99%
October, 2028 $4.9402 $7.0502 $7.4029 -34.48%
November, 2028 $5.5148 $3.8374 $4.7148 -26.86%
December, 2028 $3.1293 $4.9293 $4.6388 -58.50%

Eikon Therapeutics Inc Stock (EIKN) Price Forecast for 2029

The 2029 price forecast for Eikon Therapeutics Inc Stock (EIKN) is $9.4659 on average, with a high prediction of $16.21 and a low estimate of $2.7266. This represents an +25.54% increase from the previous price of $7.54.
Month Average Low High Change from today's price
January, 2029 $3.8576 $2.7266 $2.4403 -48.84%
February, 2029 $4.3621 $4.1312 $3.8068 -42.15%
March, 2029 $14.54 $4.4008 $13.43 +92.86%
April, 2029 $15.93 $14.72 $14.00 +111.26%
May, 2029 $17.28 $17.04 $16.21 +129.11%
June, 2029 $15.12 $15.47 $15.45 +100.55%
July, 2029 $14.00 $13.30 $13.67 +85.66%
August, 2029 $8.4351 $10.06 $13.05 +11.87%
September, 2029 $11.11 $9.1165 $9.8097 +47.36%
October, 2029 $7.1888 $7.2688 $9.4427 -4.66%
November, 2029 $7.745 $7.3319 $6.8904 +2.72%
December, 2029 $7.8426 $8.2061 $7.7963 +4.01%

Eikon Therapeutics Inc Stock (EIKN) Price Forecast for 2030

Eikon Therapeutics Inc Stock (EIKN) is expected to reach an average price of $20.53 in 2030, with a high forecast of $29.38 and a low forecast of $11.69. This signifies an +172.34% surge from the last price of $7.54.
Month Average Low High Change from today's price
January, 2030 $22.29 $22.03 $20.83 +195.60%
February, 2030 $24.42 $22.00 $21.99 +223.82%
March, 2030 $20.48 $23.35 $22.77 +171.66%
April, 2030 $16.83 $20.19 $21.74 +123.22%
May, 2030 $19.49 $19.22 $18.70 +158.46%
June, 2030 $13.86 $14.40 $17.58 +83.76%
July, 2030 $14.80 $15.01 $14.90 +96.32%
August, 2030 $11.79 $11.80 $12.33 +56.37%
September, 2030 $11.91 $11.69 $11.79 +57.92%
October, 2030 $30.44 $12.01 $27.54 +303.71%
November, 2030 $28.35 $29.12 $28.23 +275.98%
December, 2030 $30.07 $30.37 $29.38 +298.75%
$7.50
price up icon 1.35%
$10.27
price up icon 0.39%
$5.74
price up icon 5.03%
$18.93
price up icon 5.17%
$10.91
price up icon 6.03%
WVE WVE
$3.19
price up icon 3.24%
Cap:     |  Volume (24h):